Status:

COMPLETED

A Therapy to Reduce Morbidity and Hospital Length of Stay of High-Risk Surgical Patients

Lead Sponsor:

Università Politecnica delle Marche

Conditions:

High-Risk Surgical Patients

Eligibility:

All Genders

16+ years

Phase:

PHASE2

Brief Summary

Postoperative organ failures commonly occur after major abdominal surgery and substantially increase the utilization of resources and the costs of care, and are favored by tissue hypoxia. A therapeuti...

Detailed Description

The development of postoperative organ failures severely affects the prognosis of surgical patients, and substantially increases the utilization of resources and the costs of care. The presence of tis...

Eligibility Criteria

Inclusion

  • high risk surgical patients requiring major abdomina surgery

Exclusion

  • age below 16 years, preexistent neurologic, or malignant haematologic diseases

Key Trial Info

Start Date :

May 1 1995

Trial Type :

INTERVENTIONAL

End Date :

December 1 1996

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT00254150

Start Date

May 1 1995

End Date

December 1 1996

Last Update

November 15 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Azienda Ospedaliera Umberto I - U.O. Anestesia e Rianimazione Clinica

Ancona, Ancona, Italy, 60020

A Therapy to Reduce Morbidity and Hospital Length of Stay of High-Risk Surgical Patients | DecenTrialz